Commission Chief Eric Mammer stressed today that the EU’s goal is to ensure that companies with which market agreements are concluded vaccines, abide by their commitments, noting that the EU wants to see “proportionality and reciprocity”.
Mamer added that there needs to be certainty that member states have the vaccines they need, according to the Athenian-Macedonian News Agency correspondent.
Breton: Europeans will “never need Sputnik V”
Meanwhile, the producers of the Russian vaccine against covid-19 today accused European Commissioner Thierry Breton of prejudice because he said that the EU “does not need” the Sputnik V and estimated that Moscow would need European assistance.
Speaking to the French television network TF1 yesterday Sunday, as broadcast by AMPE, Breton, head of the EU Vaccine Production Task Force, assured that Europeans will not “need Sputnik V under any circumstances” as other vaccines have been approved.
“Sputnik V is a complementary vaccine, there are 350 million doses,” Breton said, explaining that “the Russians are having a hard time producing it and we will definitely need to help them.”
“If we need to offer them one or two factories for its production, why not, but for now we will see this as a priority for the Europeans in the second half of the year,” he said.
The producers of Sputnik V, for their part, criticized in a Twitter post today “the new, biased comments” against a “safe and effective vaccine”, which has been submitted to the European Medicines Agency (EMA) for approval.
“Prejudice leads to failure. “Breton’s failures are clear to many in the EU,” they wrote in the official account of the Russian vaccine.
Sputnik V, originally announced for the summer, was initially received with skepticism abroad, but in February the scientific journal The Lancet wrote that it was credible.
However, the EU criticizes Moscow for its vaccination diplomacy, accusing it of propaganda aimed at gaining influence on the international stage with the delivery of Sputnik V to several countries, albeit in small quantities.
At the same time, Russia is trying to increase its agreements abroad for the production of this vaccine against it covid-19, announcing in the last two days two agreements for the production of 400 million doses in India, among others.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
